Related Experiment Video
Updated: Jun 13, 2025
07:09
Subcutaneous Administration of Muscarinic Antagonists and Triple-Immunostaining of the Levator Auris Longus Muscle in Mice
Published on: September 8, 2011
13.6K
Classics in Chemical Neuroscience: Muscimol
Diego Rivera-Illanes1, Gonzalo Recabarren-Gajardo1,2
1Bioactive Heterocycles Synthesis Laboratory (BHSL), Departamento de Farmacia, Facultad de Química y de Farmacia, Pontificia Universidad Católica de Chile, Avenida Vicuña Mackenna 4860, Macul, Santiago 7820436, Chile.
ACS Chemical Neuroscience
|September 10, 2024
Summary
Muscimol, a psychoactive compound from Amanita mushrooms, acts as a GABA agonist. Its historical use and current research in neuroscience, particularly for neuropathic pain, highlight its significance.
Area of Science:
- Neuroscience
- Pharmacology
- Mycology
Background:
- Muscimol is a psychoactive isoxazole found in Amanita mushrooms, structurally similar to GABA.
- It functions as a potent GABAA receptor agonist, with historical use as an entheogen.
- Despite no clinical approval, it's a valuable neuroscience research tool, notably as a radioligand.
Purpose of the Study:
- To review the history, chemistry, pharmacology, and significance of muscimol.
- To explore its established and potential applications in scientific research.
- To discuss ongoing research into its therapeutic potential, such as for neuropathic pain.
Main Methods:
- Literature review of historical and contemporary scientific publications.
- Analysis of chemical structure and pharmacological properties.
- Examination of research applications, including radioligand studies.
Main Results:
- Muscimol's synthesis has been a focus since the 1960s.
- Its GABAergic activity is well-established, underpinning its use in receptor research.
- Emerging research indicates potential in managing neuropathic pain.
Conclusions:
- Muscimol holds significant importance in neuroscience research due to its GABAA agonism.
- Its historical context and ongoing therapeutic investigations underscore its multifaceted value.
- Further research is warranted to fully explore its clinical and scientific potential.
Related Concept Videos
01:25Cholinergic Receptors: Muscarinic
2.0K
The pharmacological actions of acetylcholine are elicited via its binding to two families of cholinergic receptors or cholinoceptors, namely, muscarinic and nicotinic receptors. Muscarinic receptors are G protein-coupled receptors and have five subtypes, M1–M5. All mAChR subtypes are activated by acetylcholine and blocked by the antagonist, atropine.
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
The subtypes M1, M3, and M5 couple with the Gq subunit and activate the phospholipase C (PLC) activity, mobilizing intracellular Ca2+....
2.0K
01:22Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
901
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
901
01:29Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.1K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.1K
01:28Cholinergic Antagonists: Pharmacological Actions
1.0K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.0K
01:26Neurochemical Transmission: Sites of Drug Action
2.1K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.1K
00:59Direct-Acting Cholinergic Agonists: Pharmacological Actions
1.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
1.2K